When adjusted for the type of fertility medication, the study found no association between breast cancer risk and medication-containing clomiphene citrate (OR = 0.96; 95% CI 0.54–1.72, p = 0.89) in BRCA1/2 mutation carriers. Here, BRCA1 is linked to breast carcinoma.